Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions
Yvan Jamilloux(Hospices Civils de Lyon), P. Sève(Hospices Civils de Lyon), Sébastien Viel(Université Claude Bernard Lyon 1), Thomas El Jammal(Université Claude Bernard Lyon 1), Maxime Fauter(Université Claude Bernard Lyon 1), Thomas Henry(Centre International de Recherche en Infectiologie), Alexandre Bélot(Université Claude Bernard Lyon 1), Bruno François(Inserm), Thierry Walzer(Université Claude Bernard Lyon 1)
Cited by 693
Related Papers
Assessment of the worldwide burden of critical illness: the Intensive Care Over Nations (ICON) audit
|The Lancet Respiratory Medicine|2014|1.3k
The SOFA score—development, utility and challenges of accurate assessment in clinical trials
|Critical Care|2019|976
Hydrocortisone plus Fludrocortisone for Adults with Septic Shock
|New England Journal of Medicine|2018|894
Drotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of Death
|New England Journal of Medicine|2005|890